Trial Profile
Phase II Evaluation of Irinotecan (CPT-11) in Previously Treated Advanced Sarcomas
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2005
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 15 Oct 2005 New trial record.